Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Akero Therapeutics Inc (NQ: AKRO )

44.02 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 44.02
Bid (Size) 42.39 (1)
Ask (Size) 48.30 (4)
Prev. Close 44.02
Today's Range 44.02 - 44.02
52wk Range 7.520 - 48.24
Shares Outstanding 46,763,186
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks That Hit 52-Week Lows On Friday
  On Friday, 68 companies reached new 52-week highs. 
Via Benzinga
Akero Therapeutics to Present at Upcoming Healthcare Conferences in November
From Akero Therapeutics
Via Globe NewsWire

Performance

YTD
+102.86%
+102.86%
1 Month
+15.33%
+15.33%
3 Month
+229.49%
+229.49%
6 Month
+438.14%
+438.14%
1 Year
+119.55%
+119.55%

More News

Read More
Recap: Akero Therapeutics Q3 Earnings
Via Benzinga
Thanks To Encouraging Data, These Mid-Cap Stocks Layout $300M Equity Raise
Via Benzinga
Akero Therapeutics to Present Late-Breaking Oral and Poster presentations on EFX Today at AASLD’s The Liver Meeting® 2022
From Akero Therapeutics
Via Globe NewsWire
Akero Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
From Akero Therapeutics
Via Globe NewsWire
Biotech Stocks Well-Positioned For The Fourth Quarter
Via Talk Markets
Akero Therapeutics to Present at the H.C. Wainwright 6th Annual NASH Investor Conference
From Akero Therapeutics
Via Globe NewsWire
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
Via Benzinga
Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday
Via Benzinga
Akero Therapeutics Stock Joins Elite Club Of Stocks With RS Ratings Over 90
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
Via Benzinga
Evercore ISI Group Boosts PT On This Stock By Around 400%, Plus This Analyst Predicts $100 For Merck
Via Benzinga
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
Via Benzinga
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
Via Benzinga
Dow Drops More Than 1,000 Points, Akero Therapeutics Shares Spike Higher
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Akero Therapeutics (NASDAQ: AKRO) Squeezes Shorts After Stronger-then-Expected Results from Phase 2b HARMONY Study of EFX
Via Spotlight Growth
Looking Into Akero Therapeutics's Recent Short Interest
Via Benzinga
Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Nasdaq Tumbles 500 Points, Crude Oil Down Over 1%
Via Benzinga
Akero Therapeutics Inc. (NASDAQ: AKRO) Sets New 52-Week High in Tuesday Morning Session
Via Investor Brand Network
Planet Labs, Core & Main And Some Other Big Stocks Moving Higher On Tuesday
Via Benzinga
US Stocks Open Lower After Inflation Report, Dow Dips 700 Points
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.